Literature DB >> 11997296

The pathogenesis of respiratory syncytial virus disease in childhood.

Paul S McNamara1, Rosalind L Smyth.   

Abstract

Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infection in infants and children. RSV is an RNA virus whose genome encodes 10 proteins. The G protein is responsible for viral attachment to cells whilst the F protein promotes syncytia formation. These proteins are also important in the immune response to RSV. Both the innate and adaptive arms of the cellular immune system are involved in the immunological response to RSV. The cytopathic effects of the virus explain many of the pathological findings in RSV disease. However, there is compelling evidence to suggest that the host cell immune response also has a prominent role in disease pathogenesis. Non-immunological factors may also be important.

Entities:  

Mesh:

Year:  2002        PMID: 11997296     DOI: 10.1093/bmb/61.1.13

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  51 in total

1.  Evaluation of IgG Antibodies Against Respiratory Syncytial Virus (RSV), and Associated Risk Factors for Severe Respiratory Tract Infections in Pre-School Children in North-Central, Nigeria.

Authors:  Adedayo Faneye; Babatunde O Motayo; Adeyinka Adesanmi; Bernard Onoja
Journal:  Afr J Infect Dis       Date:  2014

2.  Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.

Authors:  Bo Chi; Harold L Dickensheets; Kirsten M Spann; Marc A Alston; Cindy Luongo; Laure Dumoutier; Jiaying Huang; Jean-Christophe Renauld; Sergei V Kotenko; Mario Roederer; Judy A Beeler; Raymond P Donnelly; Peter L Collins; Ronald L Rabin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 3.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

4.  Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.

Authors:  Annemieke Schuurhof; Louis Bont; Jeroen L A Pennings; Hennie M Hodemaekers; Piet W Wester; Annemarie Buisman; Lia C G H de Rond; Myra N Widjojoatmodjo; Willem Luytjes; Jan L L Kimpen; Riny Janssen
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Host transcription profiles upon primary respiratory syncytial virus infection.

Authors:  Riny Janssen; Jeroen Pennings; Hennie Hodemaekers; Annemarie Buisman; Marijke van Oosten; Lia de Rond; Kemal Oztürk; Jan Dormans; Tjeerd Kimman; Barbara Hoebee
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  The impact of temperature and relative humidity on spatiotemporal patterns of infant bronchiolitis epidemics in the contiguous United States.

Authors:  Chantel Sloan; Matthew Heaton; Sorah Kang; Candace Berrett; Pingsheng Wu; Tebeb Gebretsadik; Nicholas Sicignano; Amber Evans; Rees Lee; Tina Hartert
Journal:  Health Place       Date:  2017-03-10       Impact factor: 4.078

Review 7.  Management of paediatric asthma.

Authors:  J Grigg
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

Review 8.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure.

Authors:  Martin C J Kneyber; Marc van Heerde; Jos W R Twisk; Frans B Plötz; Dick G Markhors
Journal:  Crit Care       Date:  2009-05-15       Impact factor: 9.097

10.  Human metapneumovirus in severe respiratory syncytial virus bronchiolitis.

Authors:  Julie Greensill; Paul S McNamara; Winifred Dove; Brian Flanagan; Rosalind L Smyth; C Anthony Hart
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.